Skip to main content
Thomas Slavin Jr., MD, Medical Genetics, Duarte, CA, City of Hope Comprehensive Cancer Center

ThomasSlavinJr.MD

Medical Genetics Duarte, CA

Clinical Genetics, Pediatric Medical Genetics

Assistant Clinical Professor, City of Hope

Dr. Slavin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Slavin's full profile

Already have an account?

Summary

  • Dr. Thomas Slavin is a medical geneticist in Duarte, CA and is affiliated with City of Hope's Helford Clinical Research Hospital. He received his medical degree from University of South Florida College of Medicine and has been in practice 12 years. He specializes in clinical cancer genetics.

Education & Training

  • Case Western Reserve University/University Hospitals Cleveland Medical Center
    Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Pediatrics/Medical Genetics and Genomics, 2005 - 2010
  • Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens Hospital
    Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens HospitalResidency, Pediatrics, 2005 - 2008
  • University of South Florida College of Medicine
    University of South Florida College of MedicineClass of 2005
  • University of South Florida
    University of South FloridaB.S., Biology, Cum Laude, 1997 - 2001

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2014 - 2024
  • HI State Medical License
    HI State Medical License 2010 - 2016
  • OH State Medical License
    OH State Medical License 2005 - 2012
  • American Board of Pediatrics Pediatrics
  • American Board of Medical Genetics and Genomics Clinical Genetics and Genomics
  • American Board of Clinical ChemistryBoard certification in Molecular Diagnostics

Awards, Honors, & Recognition

  • Research Career Development Award Recipient STOP CANCER, 2015
  • Fellow American College of Medical Genetics and Genomics, 2012
  • Pediatric Residency International Health Track Distinction (Roatan, Honduras) 2008
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Specifications of the ACMG/AMP Variant Curation Guidelines for the Analysis of Germline CDH1 Sequence Variants  
    Sharon E Plon, Chimene Kesserwan, Thomas P Slavin, Liying Zhang, Human Mutation
  • Clinical application of multigene panels: challenges of next-generation counseling and cancer risk management  
    Slavin TP, Niell-Swiller M, Solomon I, Nehoray B, Rybak C, Blazer KR, Weitzel JN, Front. Oncol., 1/29/2015
  • Congenital diaphragmatic hernia in a fetus with a de novo terminal deletion of chromosome 15q261  
    Ruth C, Starcevic J, Bartholomew ML, Qin N, Slavin TP, Hereditary Genetics, 1/1/2012

Books/Book Chapters

Abstracts/Posters

  • Multiplex Identification of genetic etiologies among women with bilateral breast cancer using a 25gene hereditary cancer panel.
    Weitzel JN, Blazer KR, Nehoray B, Kidd J, Slavin TP, Solomon I, Niell-Swiller M, Rybak C, Saam J, Lancaster J, San Antonio Breast Cancer Symposium, NM, 1/1/2015
  • How big of a role does TP53 play in BRCA1/2 negative familial breast cancer? Data from the SIMPLEXO consortium.
    Slavin TP, Maxwell KN, Hart S, Vijai J, Schrader K, Guidugli L, Thomas T, Moore R, Hu C, Wubbenhorst B, Domchek SM, Robson ME, Radice P, Peterlongo P, Ford J, Garber J..., American Society of Human Genetics Annual Meeting, Baltimore, MD, 1/1/2015
  • The contribution of high and moderate penetrance breast cancer susceptibility genes to familial breast cancer risk in BRCAx families.
    Maxwell KN, Hart S, Vijai J, Schrader K, Slavin TP, Thomas T, Moore R, Hu C, Wubbenhorst B, Domchek SM, Robson ME, Radice P, Peterlongo P, Ford J, Garber J, Szabo C, N..., American Society of Human Genetics Annual Meeting, 1/1/2015
  • Join now to see all

Lectures

  • Effect of germline ATM mutations on clonal hematopoiesis. 
    2019 ASCO Annual Meeting - 6/1/2019
  • Understanding the NGS Test report: a primer on genomics nomenclature. 
    1/27/2015
  • Updates in Li Fraumeni syndrome screening. 
    City of Hope - 1/26/2015
  • Join now to see all

Other

  • "Genodermatoses in cancer" 
    Slavin TP, Intensive Course in Cancer Genetics (Video)
    City of Hope - 1/10/2014
  • Visual Diagnosis: Newborn with Unilateral Lower Extremity Vascular Malformation and Limb Asymmetry. 
    Wong Ramsey K, Slavin TP, Tjoeng T, Jain S, NeoReviews Vol. 15 No. 2
    http://neoreviews.aappublications.org/content/15/2/e82.short
    1/1/2014
  • "Genetic Testing" 
    Slavin TP, The Body Show with Kathy Kozak, Hawai'i Public Radio
    1/10/2013

Press Mentions

  • Myriad Genetics Patient Outcomes Study Shows RiskScore Leads to More Accurate Breast Cancer Risk Prediction Than Standard-of-Care Risk Model
    Myriad Genetics Patient Outcomes Study Shows RiskScore Leads to More Accurate Breast Cancer Risk Prediction Than Standard-of-Care Risk ModelDecember 9th, 2022
  • What Causes Breast Cancer, Exactly? Doctors Explain What We Know—and How Testing Can Help
    What Causes Breast Cancer, Exactly? Doctors Explain What We Know—and How Testing Can HelpMay 5th, 2022
  • Genomic Instability Varies Between Breast Cancer Subtypes
    Genomic Instability Varies Between Breast Cancer SubtypesDecember 10th, 2021
  • Join now to see all

Hospital Affiliations